Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

1,836

Participants

Timeline

Start Date

July 8, 2002

Conditions

Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin DiseaseNonHodgkin LymphomaMixed Lymphoproliferative Disease

Trial Locations (2)

NIH National Cancer Institute - Shady Grove, Rockville

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH